Patent details

EP1387691 Title: BLOOD COAGULATION FACTOR XIII FOR TREATING PLATELET DISORDERS

Basic Information

Publication number:
EP1387691
PCT Application Number:
PCT/US/2002/003770
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027231174
PCT Publication Number:
WO/2002/067981
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BLOOD COAGULATION FACTOR XIII FOR TREATING PLATELET DISORDERS
French Title of Invention:
FACTEUR XIII DE COAGULATION SANGUINE PERMETTANT DE TRAITER DES PATHOLOGIES PLAQUETTAIRES
German Title of Invention:
BLUTGERINNUNGSFAKTOR XIII ZUR BEHANDLUNG VON PLÄTTCHENFUNKTIONSSTÖRUNGEN
SPC Number:

Dates

Filing date:
07/02/2002
Grant date:
16/08/2006
EP Publication Date:
16/08/2006
PCT Publication Date:
06/09/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/02/2004
EP B1 Publication Date:
16/08/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/02/2009
Expiration date:
07/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/02/2002
 
 

Name:
ZymoGenetics Inc.
Address:
1201 Eastlake Avenue East, Seattle, WA 98102, United States (US)

Inventor

Name:
BISHOP Paul, D.
Address:
United States (US)

Priority

Priority Number:
270470 P
Priority Date:
21/02/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages